Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Undervalued stocks
Momentum stocks
ESG stocks
Growth stocks
Trend-Following Stocks
Quality stocks
Investment Themes
Hydrogen
Smart City
The future of mobility
The Golden Age of Video Games
Ageing Population
Let's all cycle!
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Boats
Sin stocks
Education
The future of mobility
Fintechs
US Basketball
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
Our subscriptions
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Gritstone bio, Inc.
News
Summary
GRTS
US39868T1051
GRITSTONE BIO, INC.
(GRTS)
Add to my list
Report
Delayed Nasdaq -
04:00 2022-08-18 pm EDT
4.490
USD
+2.51%
08/17
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/15
Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors
AQ
08/15
Gritstone bio, Inc. Publishes Interim Results from Gritstone bios Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors
CI
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Gritstone bio, Inc.(NasdaqGS:GRTS) dropped from Russell 2000 Value Index
06/24/2022 | 12:00am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
Gritstone bio, Inc.(NasdaqGS:GRTS) dropped from Russell 2000 Value Index
© S&P Capital IQ 2022
All news about GRITSTONE BIO, INC.
08/17
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/15
Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of GRANI..
AQ
08/15
Gritstone bio, Inc. Publishes Interim Results from Gritstone bios Phase 1/2 Study..
CI
08/10
GRITSTONE BIO
: Appoints Dr. Lawrence “Larry” Corey to its Board of Directors ..
PU
08/10
GRITSTONE BIO, INC.
: Change in Directors or Principal Officers, Financial Statements and ..
AQ
08/10
Gritstone Appoints Dr. Lawrence “Larry” Corey to its Board of Directors
AQ
08/10
Gritstone Appoints Dr. Lawrence Larry Corey to Its Board of Directors, Effe..
CI
08/04
GRITSTONE BIO
: Reports Second Quarter 2022 Financial Results and Provides Business Update..
PU
08/04
GRITSTONE BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
08/04
Earnings Flash (GRTS) GRITSTONE BIO Reports Q2 Revenue $5.5M
MT
More news
Analyst Recommendations on GRITSTONE BIO, INC.
05/09
HC Wainwright Lowers Gritstone bio's Price Target to $12 From $15, Maintains Buy Rating
MT
03/14
HC Wainwright Adjusts Gritstone Bio's Price Target to $15 From $24, Maintains Buy Ratin..
MT
2021
GRITSTONE ONCOLOGY
: BTIG Research Adjusts Gritstone Oncology PT to $35 From $17, Maintain..
MT
More recommendations
Financials (USD)
Sales 2022
19,2 M
-
-
Net income 2022
-123 M
-
-
Net cash 2022
23,0 M
-
-
P/E ratio 2022
-2,90x
Yield 2022
-
Capitalization
328 M
328 M
-
EV / Sales 2022
15,9x
EV / Sales 2023
23,6x
Nbr of Employees
193
Free-Float
97,0%
More Financials
Chart GRITSTONE BIO, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends GRITSTONE BIO, INC.
Short Term
Mid-Term
Long Term
Trends
Bullish
Neutral
Bearish
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4,49 $
Average target price
11,33 $
Spread / Average Target
152%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Andrew R. Allen
President, Chief Executive Officer & Director
Vassiliki Celia Economides
Chief Financial Officer & Executive Vice President
Elaine V. Jones
Chairman
Karin Jooss
Head-Research & Development
Erin E. Jones
Chief Operating Officer
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
GRITSTONE BIO, INC.
-65.94%
320
CSL LIMITED
0.61%
97 468
SAMSUNG BIOLOGICS CO.,LTD.
-3.10%
47 101
WUXI BIOLOGICS (CAYMAN) INC.
-24.64%
37 923
BIOGEN INC.
-9.31%
31 574
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
-25.52%
22 656
More Results
Slave